Clinical Trials We Are Funding
Clinical trials are one of the final stages of a long and careful cancer research process. They can only take place after satisfactory information has been gathered from laboratory research, including cell cultures and animal models. Even the most promising scientific findings must first be proven to be safe and effective in clinical trials before they can be used as standard treatment. The cancer treatments that are used today were developed and tested in clinical trials. Through our research grants, we have supported more than 500 clinical trials.
Our trials examine a broad range of areas:
- Identifying the causes of breast cancer
- New approaches to cancer prevention, including preventative drugs, nutritional approaches and changes in lifestyle and behavior
- New methods for early detection, screening and diagnosis of breast cancer including new technologies like ultrasound tomography and blood tests that measure biomarkers
- New approaches to surgery and radiation therapy
- New anticancer drugs for breast cancer, including chemotherapy, hormonal therapy, targeted therapy and immunotherapy agents
- New combinations of treatments
- Complementary and alternative cancer therapies
- Supportive care to understand the impact and identify the needs breast cancer patients and their families, and test new approaches for communicating about breast health
- Quality of life studies for alleviating side-effects of breast cancer treatment
Learn more about what Komen is doing to help people with any stage of breast cancer find and participate in clinical trials.
Bringing the Patient Voice to Research
Breast cancer survivors and advocates are involved in our scientific research.